Morphic Holding Inc (MORF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MORF | AMGN | VRTX | GILD | BMY |
| Company | Morphic Holding Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 56.98 | 275.01 | 458.06 | 93.50 | 58.84 |
| High | 57.00 | 275.36 | 465.90 | 94.22 | 59.53 |
| Low | 56.97 | 271.48 | 456.86 | 92.03 | 58.69 |
| Last | 56.99 | 272.58 | 462.10 | 92.13 | 59.38 |
| Change | +0.02 | -1.75 | +2.18 | -1.26 | +0.54 |
| % Change | +0.04% | -0.64% | +0.47% | -1.35% | +0.92% |
| Volume | 1,795,800 | 3,970,300 | 1,115,300 | 4,470,700 | 7,277,000 |
| 20-Day Average Volume | 1,792,620 | 4,673,665 | 1,376,875 | 7,318,660 | 11,103,835 |
| Previous Close | 56.97 | 274.33 | 459.92 | 93.39 | 58.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 56.76 | 288.82 | 469.52 | 91.82 | 58.37 |
| 20-Day Raw Stochastic | 98.46% | 20.98% | 22.84% | 47.19% | 76.09% |
| 20-Day Relative Strength | 79.44% | 31.35% | 46.49% | 55.67% | 60.90% |
| Weighted Alpha | +24.00 | -7.29 | +22.48 | +25.80 | +27.82 |
| Today's Opinion | 100% Buy | 72% Sell | 24% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 72% Sell | 24% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 24% Buy | 88% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.19% since 08/08/24 | -3.64% since 11/29/24 | -1.29% since 11/29/24 | -0.49% since 11/29/24 | +0.27% since 11/29/24 |
| Low | 56.89 on 08/09/24 | 271.48 on 12/06/24 | 450.00 on 12/04/24 | 89.86 on 12/04/24 | 57.59 on 12/04/24 |
| High | 57.00 on 08/15/24 | 282.39 on 12/02/24 | 468.51 on 12/03/24 | 94.39 on 12/03/24 | 60.09 on 12/03/24 |
| 1-Month | |||||
| %Chg | +1.90% since 07/15/24 | -15.29% since 11/06/24 | -6.39% since 11/06/24 | +0.48% since 11/06/24 | +7.42% since 11/06/24 |
| Low | 55.91 on 07/16/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 | 53.97 on 11/08/24 |
| High | 57.00 on 08/15/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 3-Month | |||||
| %Chg | +88.52% since 05/15/24 | -14.97% since 09/06/24 | -1.26% since 09/06/24 | +17.04% since 09/06/24 | +21.93% since 09/06/24 |
| Low | 25.25 on 06/18/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 78.36 on 09/09/24 | 47.55 on 09/09/24 |
| High | 57.00 on 08/15/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | +47.45% since 02/15/24 | -10.83% since 06/06/24 | -4.83% since 06/06/24 | +44.29% since 06/06/24 | +45.25% since 06/06/24 |
| Low | 25.25 on 06/18/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 | 39.35 on 07/05/24 |
| High | 57.00 on 08/15/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,854,857 | 146,520,736 | 119,004,152 | 114,818,480 | 120,433,152 |
| Shares Outstanding, K | 50,094 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 520,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -152,100,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -57,590,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.49 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.15 on 07/25/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 08/01/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 12/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.27 | 0.00 | 21.08 | 50.29 |